Javascript must be enabled to continue!
The Microglial Trem2 R47H Alzheimer’s Disease Risk Variant Impairs Early Hippocampal Synaptic Remodeling
View through CrossRef
Summary
The rare R47H variant of the microglial
TREM2
gene increases Alzheimer’s disease (AD) risk, but its effects on early hippocampal circuitry remain unclear. We examined basal synaptic transmission and synaptic density in 3-week-old
Trem2
R47H knockin mice using
in vitro
whole-cell patch clamp recordings and immunohistochemistry. R47H mice displayed increased synaptic density in CA1 and CA3 regions, consistent with a trend towards increased spontaneous excitatory current frequency. Evoked synaptic currents, miniature EPSCs and spontaneous inhibitory current frequency were unaltered. Microglia shape synaptic circuits in early development by removing inactive synapses. Thus, inhibition of this role due to the
Trem2
R47H mutation decreases the microglial reshaping of hippocampal connectivity during early postnatal development, without overtly altering basal synaptic activity. With ongoing synaptic plasticity, such early structural changes may predispose neural circuits to later dysfunction, particularly in the context of AD pathology, highlighting the importance of microglial TREM2 in developmental synaptic refinement.
Title: The Microglial
Trem2
R47H Alzheimer’s Disease Risk Variant Impairs Early Hippocampal Synaptic Remodeling
Description:
Summary
The rare R47H variant of the microglial
TREM2
gene increases Alzheimer’s disease (AD) risk, but its effects on early hippocampal circuitry remain unclear.
We examined basal synaptic transmission and synaptic density in 3-week-old
Trem2
R47H knockin mice using
in vitro
whole-cell patch clamp recordings and immunohistochemistry.
R47H mice displayed increased synaptic density in CA1 and CA3 regions, consistent with a trend towards increased spontaneous excitatory current frequency.
Evoked synaptic currents, miniature EPSCs and spontaneous inhibitory current frequency were unaltered.
Microglia shape synaptic circuits in early development by removing inactive synapses.
Thus, inhibition of this role due to the
Trem2
R47H mutation decreases the microglial reshaping of hippocampal connectivity during early postnatal development, without overtly altering basal synaptic activity.
With ongoing synaptic plasticity, such early structural changes may predispose neural circuits to later dysfunction, particularly in the context of AD pathology, highlighting the importance of microglial TREM2 in developmental synaptic refinement.
Related Results
TREM2 knockout, but not the R47H Alzheimer’s variant, reduces neural phagocytosis and survival of human iPSC-derived macrophages
TREM2 knockout, but not the R47H Alzheimer’s variant, reduces neural phagocytosis and survival of human iPSC-derived macrophages
Abstract
BACKGROUND: TREM2 is a microglial cell surface receptor, with risk mutations linked to Alzheimer’s disease (AD), including R47H. Binding of ligands to TREM2 trigge...
Genetic models of cleavage-reduced and soluble TREM2 reveal distinct effects on myelination and microglia function in the cuprizone model
Genetic models of cleavage-reduced and soluble TREM2 reveal distinct effects on myelination and microglia function in the cuprizone model
Abstract
Triggering receptor expressed on myeloid cells 2 (TREM2) is a cell-surface immunoreceptor expressed on microglia, osteoclasts, dendritic cells and macrop...
Soluble TREM2 induces microglia dysfunction and brain damage while cleavage-reduced TREM2 shows sustained microglia activation with enhanced myelination in the cuprizone model
Soluble TREM2 induces microglia dysfunction and brain damage while cleavage-reduced TREM2 shows sustained microglia activation with enhanced myelination in the cuprizone model
Abstract
Triggering receptor expressed on myeloid cells 2 (TREM2) is a cell-surface immunoreceptor expressed on microglia, osteoclasts, dendritic cells andmacrophages. Hete...
Soluble TREM2 induces microglia dysfunction and brain damage while cleavage-reduced TREM2 shows sustained microglia activation with enhanced remyelination in the cuprizone model
Soluble TREM2 induces microglia dysfunction and brain damage while cleavage-reduced TREM2 shows sustained microglia activation with enhanced remyelination in the cuprizone model
Abstract
Triggering receptor expressed on myeloid cells 2 (TREM2) is a cell-surface immunoreceptor expressed on microglia, osteoclasts and monocytes/macrophages. In humans,...
Characterization of the first TREM2 small molecule agonist, VG‐3927, for clinical development in Alzheimer’s disease
Characterization of the first TREM2 small molecule agonist, VG‐3927, for clinical development in Alzheimer’s disease
AbstractBackgroundTREM2 is a lipid‐sensing receptor expressed by microglial sub‐populations within neuropathological microenvironments, whose downstream signaling promotes microgli...
Use of CRISPR/Cas9 Gene Editing Methods to Investigate the Mechanism of Trem2-Dependent Gene Expression in Macrophages
Use of CRISPR/Cas9 Gene Editing Methods to Investigate the Mechanism of Trem2-Dependent Gene Expression in Macrophages
Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) is a surface receptor expressed in macrophages during tissue injury. This receptor plays a role in driving phagocytosis and...
TREM2 expression in the human brain: a marker of monocyte recruitment?
TREM2 expression in the human brain: a marker of monocyte recruitment?
AbstractMutation in the triggering receptor expressed on myeloid cells (TREM) 2 gene has been identified as a risk factor for several neurodegenerative diseases including Alzheimer...
Cyclophilin A is an endogenous ligand for the triggering receptor expressed on myeloid cells‐2 (TREM2)
Cyclophilin A is an endogenous ligand for the triggering receptor expressed on myeloid cells‐2 (TREM2)
Abstract
Triggering receptor expressed on myeloid cells 2 (TREM2) is a cell surface receptor expressed on macrophages, microglial cells, and ...

